Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines 2019

Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Mar 02, 2019 at Memorial Sloan Kettering Cancer Center - Rockefeller Research Laboratories, New York City, New York, United States of America.

The target audience for this medical event is Psychiatrists, Psycho-oncologists, Oncologists, General Practitioners, Palliative Care Physicians, Physician Assistants, Nurse Practitioners, Nurses, Psychologists, Social Workers and Counselors.

Accreditation

AMA Credit Designation Statement
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Social Work Accreditation Statement
This presentation is approved for a maximum of 6.50 Continuing Education Contact Hours of Live In-Person/Live Online Training. Memorial Sloan-Kettering Cancer Center is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0228.

ANCC CNE Statement
MSK Department of Nursing was awarded Accreditation with Distinction by American Nurses Credentialing Center (ANCC) as a provider of continuing nursing education. Nursing Credits – 6.50 CNE contact hours will be awarded to participants who attend a live program, in its entirety, and complete a program evaluation. Partial credit not awarded.

Course Description: 
Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.

This course is designed for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology. Oncologists, palliative care clinicians, advanced practice nurses and oncology nurses will find this course useful as well. The course will focus on key target disorders and symptoms amenable to psychopharmacological intervention, including anxiety, depression, delirium, insomnia, pain, fatigue and cachexia. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments.

Basic information will be presented about medications used to alleviate Quality of Life symptoms that arise in the cancer setting from diagnosis to survivorship or end of life care, and the interface of psychotherapy and medication management. We will review why certain medications are used and why some are avoided, looking at potential benefits, unwanted side effects, and drug-drug interactions, since you may be the first person to identify a serious adverse event. The course will also enhance your ability to provide psychoeducation to patients regarding psychiatric medications.

Course Objectives: 
• Participants will learn basic psycho-pharmaco-oncology and how to hone essential clinical and observation skills to improve the quality of life, mental health and safety of their patients by understanding the basics of the psychophysiology of cancer.

Early Registration Fees:
Physicians (MD, DO, MBBS or equivalent) Early Fee: $200 
Residents, Fellows, NPs, PAs, RNs, Psychologists, Social Workers and Counselors: $100
Industry Professionals: $375

Early Registration expires January 4, 2019